Metraipolis › archive › dc_2d259df4a3e2
A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer — Europe PMC PMID:41293150
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41293150
- DOI
- 10.3389/fimmu.2025.1676768
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:45:00.559Z
- SHA-256 of the archived text
afc56f20a6f2a23b5c57985eb31eb7b513bdc516573d4dbb8ed3fe63ae724d2f- Stable URL of this page
https://metraipolis.com/documento/dc_2d259df4a3e2
How to cite
A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer — Europe PMC PMID:41293150 — Europe PMC (en), https://europepmc.org/article/MED/41293150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d259df4a3e2 (Metraipolis archive dc_2d259df4a3e2, sha256 afc56f20a6f2a23b5c57985eb31eb7b513bdc516573d4dbb8ed3fe63ae724d2f)
BibTeX
@misc{dc2d259df4a3e2,
title = {A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer — Europe PMC PMID:41293150},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41293150},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d259df4a3e2; sha256 afc56f20a6f2a23b5c57985eb31eb7b513bdc516573d4dbb8ed3fe63ae724d2f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41293150. Agents can read the archived copy with the MCP tool read_document.